ENDO GIA
Report
- Report Number
- 1219930-2025-01919
- Event Type
- Injury
- Date Received
- April 23, 2025
- Date of Event
- March 27, 2025
- Report Date
- July 2, 2025
- Manufacturer
- COVIDIEN LP LLC NORTH HAVEN
- Product Code
- GDW
- UDI-DI
- 10884523003215
- PMA / PMN Number
- K111825
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- OTHER
- Health Professional
- N
Narratives
D10 CONCOMITANT MEDICAL PRODUCTS: SIGPHANDLE, SIG POWER SIGPHANDLE HANDLE (SN:UNKNOWN); SIGPSHELL, SIG POWER SIGPSHELL CONTROL SHELL (LOT#UNKNOWN); SIGADAPTSTND, SIG POWER SIGADAPTSTND LINEAR ADAPTER (SN:UNKNOWN) MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.
H3 EVALUATION SUMMARY: MEDTRONIC CONDUCTED AN INVESTIGATION BASED UPON ALL INFORMATION RECEIVED. THE DEVICE WAS NOT RETURNED, BUT A PHOTO WAS AVAILABLE FOR EVALUATION. VISUAL INSPECTION OF THE RETURNED PHOTO NOTED ONE IMAGE OF A STAPLE LINE. BLOOD COULD BE SEEN ON THE TISSUE. STAPLES COULD NOT BE PROPERLY EXAMINED FOR PROPER FORMATION DUE TO IMAGE QUALITY. THE LISTED RELOAD WAS NOT VISIBLE IN THE RETURNED IMAGE. IT WAS REPORTED THAT THERE WAS STAPLE LINE BLEEDING. THE REPORTED ISSUE WAS CONFIRMED. THE MOST LIKELY CAUSE COULD NOT BE ESTABLISHED FROM THE INFORMATION AVAILABLE. IT WAS ALSO REPORTED THAT THERE WAS ISSUE WITH STAPLE FORMATION. THE REPORTED ISSUE COULD NOT BE CONFIRMED. THE MOST LIKELY CAUSE COULD NOT BE ESTABLISHED FROM THE INFORMATION AVAILABLE. THE MANUFACTURING RECORDS FOR EACH DEVICE ARE THOROUGHLY REVIEWED PRIOR TO RELEASE TO ENSURE THAT IT MEETS ALL MEDTRONIC QUALITY SPECIFICATIONS. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.
ACCORDING TO THE REPORTER, POSTOPERATIVE TO THE HINOTORI LEFT HEMICOLECTOMY PROCEDURE, BLEEDING OCCURRED NEAR THE ANASTOMOTIC SITE, REQUIRING A BLOOD TRANSFUSION AND THE APPLICATION OF A CLIP VIA ENDOSCOPY. IT WAS UNCLEAR WHETHER THE STAPLER CAUSED THE BLEEDING, THOUGH A POTENTIAL ISSUE WITH STAPLE FORMATION WAS SUSPECTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1124234 | ENDO GIA | STAPLE, IMPLANTABLE | GDW | COVIDIEN LP LLC NORTH HAVEN | EGIA60AMT | 10884523003215 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Required Intervention| L |